Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Olfactory receptor 10A3 is a member of the large family of G protein-coupled receptors (GPCRs), sharing a seven-transmembrane domain structure commonly found in many neurotransmitter and hormone receptors[1][3][6][7]. Traditionally known for recognizing odorant molecules within the nasal epithelium to initiate neuronal responses for smell perception, OR10A3 also exhibits ectopic activity in non-olfactory tissues. In human dermal fibroblasts, activation by suberic acid counteracts ultraviolet B–induced reductions in collagen synthesis, supporting extracellular matrix integrity and implicating OR10A3 as a potential therapeutic target to maintain or restore skin structure and function, particularly in anti-aging contexts. Its gene family is the largest in the human genome, and olfactory receptor nomenclature is species-specific[1][6][7].
Ligand binding (suberic acid) induces activation of the cAMP–Akt signaling pathway, increasing collagen production and potentially protecting against UVB-induced photoaging
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Olfactory receptor 10A3 (OR10A3).